SCHEMBL25910178

SCHEMBL25910178

CC(C)Nc1ncc(-c2ccc3cc(Oc4ccnc(N)c4)cnc3n2)c(=O)n1C

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 7/20 0.52
▸ PDGFRA P16234 5/20 0.52
▸ PDGFRB P09619 3/20 0.52
▸ FLT3 P36888 2/20 0.52
▸ LCK P06239 1/20 0.52
▸ KIT P10721 1/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ PTK6 Q13882 1/20 0.52
▸ KDR P35968 1/20 0.36
▸ P2RX3 P56373 1/20 0.32
▸ SYK P43405 2/20 0.31
▸ PIM1 P11309 1/20 0.31
▸ PIM2 Q9P1W9 1/20 0.31
▸ FEN1 P39748 1/20 0.31
▸ NOS3 P29474 1/20 0.30
▸ NOS1 P29475 1/20 0.30
▸ NOS2 P35228 1/20 0.30
▸ FGFR1 P11362 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25319458 0.89 CSF1R (0.52) CSF1RPDGFRAPDGFRBFLT3LCK
SCHEMBL25910028 0.88 CSF1R (0.53) CSF1RPDGFRAPDGFRBFLT3LCK
SCHEMBL25910168 0.85 CSF1R (0.54) CSF1RPDGFRAPDGFRBFLT3LCK
SCHEMBL25910177 0.85 PDGFRB (0.51) CSF1RPDGFRAPDGFRBFLT3LCK
SCHEMBL25910698 0.85 CSF1R (0.48) CSF1RPDGFRAPDGFRBFLT3LCK
SCHEMBL25910024 0.85 CSF1R (0.74) CSF1RPDGFRAPDGFRBFLT3LCK
SCHEMBL25912017 0.85 CSF1R (0.49) CSF1RPDGFRAPDGFRBFLT3LCK
SCHEMBL25910708 0.84 CSF1R (0.49) CSF1RPDGFRAPDGFRBFLT3LCK
SCHEMBL25910911 0.84 CSF1R (0.49) CSF1RPDGFRAPDGFRBFLT3LCK
SCHEMBL25910702 0.84 CSF1R (0.48) CSF1RPDGFRAPDGFRBFLT3LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125812-A1 SUBSTITUTED PYRIMIDONE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND MEDICAL USE THEREOF 上海海雁医药科技有限公司 2023-07-06 — — WO disclosed
Send feedback